Beta infection combined with Pfizer BNT162b2 vaccination leads to broadened neutralizing immunity against Omicron
暂无分享,去创建一个
A. Sigal | W. Hanekom | G. Lustig | S. Cele | K. Khan | F. Karim | N. Magula | M. Mazibuko | N. Samsunder | Y. Ganga | Y. Moosa | T. D. de Oliveira | Shi-Hsia Hwa | M. Bernstein | B. Gosnell | R. Lessells | Z. Jule | K. Reedoy | N. Manickchund | COMMIT-KZN Team | S. A. Karim
[1] A. Sigal. Milder disease with Omicron: is it the virus or the pre-existing immunity? , 2022, Nature Reviews Immunology.
[2] D. von Laer,et al. SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons , 2022, The New England journal of medicine.
[3] T. Ndung’u,et al. Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization , 2021, Nature.
[4] Chaim A. Schramm,et al. Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates , 2021, Science.
[5] T. Ndung’u,et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma , 2021, Nature.